Medistim ASA (Norway) Today
| MEDI Stock | NOK 154.50 4.50 2.83% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Medistim ASA is selling for 154.50 as of the 27th of November 2024. This is a 2.83% down since the beginning of the trading day. The stock's lowest day price was 153.5. Medistim ASA has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Medistim ASA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. MEDISTIM ASA operates under Medical Equipment classification in Norway and is traded on Oslo Stock Exchange. The company has 18.26 M outstanding shares. More on Medistim ASA
Moving together with Medistim Stock
Moving against Medistim Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medistim Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medistim ASA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medistim ASA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Medistim ASA (MEDI) is traded on Oslo Stock Exchange in Norway and employs 116 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medistim ASA's market, we take the total number of its shares issued and multiply it by Medistim ASA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medistim ASA operates under Healthcare sector and is part of Medical Devices industry. The entity has 18.26 M outstanding shares.
Medistim ASA has accumulated about 129.49 M in cash with 128.14 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.99.
Check Medistim ASA Probability Of Bankruptcy
Ownership AllocationMedistim ASA maintains a total of 18.26 Million outstanding shares. The majority of Medistim ASA outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medistim ASA to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medistim ASA. Please pay attention to any change in the institutional holdings of Medistim ASA as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medistim Ownership Details
Medistim ASA Risk Profiles
Although Medistim ASA's alpha and beta are two of the key measurements used to evaluate Medistim ASA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.93 | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.1 | |||
| Risk Adjusted Performance | (0.01) |
Medistim Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medistim ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Medistim ASA Corporate Management
Elected by the shareholders, the Medistim ASA's board of directors comprises two types of representatives: Medistim ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medistim. The board's role is to monitor Medistim ASA's management team and ensure that shareholders' interests are well served. Medistim ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medistim ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Jakobsen | Chief Officer | Profile | |
| Ole Robsrud | CEO AS | Profile | |
| Hakon Grothe | Chief Officer | Profile | |
| Roger Morberg | VP Sales | Profile | |
| Kari Krogstad | CEO Pres | Profile | |
| Helge Borslid | VP Manufacturing | Profile | |
| Mike Farbelow | Pres Inc | Profile |
Other Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.